TrialThe Korean journal of internal medicine2019

Efficacy and safety of alirocumab in Korean patients with hypercholesterolemia and high cardiovascular risk: subanalysis of the ODYSSEY-KT study.

Chang-Wook Nam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.